Aug. 23 at 4:38 AM
$CADL Very interesting...
I'm sure IDEA Pharma must be contributing something to Candel Therapeutics' strategy.
But I remain very critical of this alliance, because the stock price has dropped significantly since the announcement of this agreement, from
$8.30 to less than
$6?
The indices are at all-time highs, so why isn't it being valued at a much higher price?
Why aren't the market and large investors valuing this strategy if it's sound, according to the CEO?
I've always supported Dr. Tak and will continue to do so, but there's something the market and large investors don't like, and I don't know what it is. The other option, which isn't far-fetched, is that they're buying all the shares they can at low prices. But if that were the case, the price should have been in double digits for a long time as the float became narrower, but that's not happening.
Does anyone have any idea why the market isn't valuing Candel's strategy much more highly?
https://media.stocktwits-cdn.com/api/3/media/6593442/medium.jpg
